Literature DB >> 24115682

Intermittent X-linked thrombocytopenia with a novel WAS gene mutation.

Taizo Wada1, Masatsune Itoh, Hideaki Maeba, Tomoko Toma, Yo Niida, Yutaka Saikawa, Akihiro Yachie.   

Abstract

X-linked thrombocytopenia (XLT) is caused by mutations in the WAS gene and characterized by thrombocytopenia with minimal or no immunodeficiency. Patients with XLT usually exhibit persistent thrombocytopenia, and intermittent thrombocytopenia has been described only in two families. Here, we report a patient with intermittent XLT carrying a novel missense mutation (Ala56Thr). He showed residual expression of Wiskott-Aldrich syndrome protein in the lymphocytes and platelets. There appeared to be an association between normal platelet numbers and a post infectious state. Our findings further support the importance of analysis of Wiskott-Aldrich syndrome protein in male patients who exhibit fluctuating courses of thrombocytopenia.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  WASp; Wiskott-Aldrich syndrome; X-linked thrombocytopenia; intermittent thrombocytopenia; missense mutation

Mesh:

Substances:

Year:  2013        PMID: 24115682     DOI: 10.1002/pbc.24787

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  2 in total

1.  Intermittent low platelet counts hampering diagnosis of X-linked thrombocytopenia in children: report of two unrelated cases and a novel mutation in the gene coding for the Wiskott-Aldrich syndrome protein.

Authors:  Samuel Souza Medina; Lúcia Helena Siqueira; Marina Pereira Colella; Gabriela Goes Yamaguti-Hayakawa; Bruno Kosa Lino Duarte; Maria Marluce Dos Santos Vilela; Margareth Castro Ozelo
Journal:  BMC Pediatr       Date:  2017-06-22       Impact factor: 2.125

2.  Whole Wiskott‑Aldrich syndrome protein gene deletion identified by high throughput sequencing.

Authors:  Xiangling He; Runying Zou; Bing Zhang; Yalan You; Yang Yang; Xin Tian
Journal:  Mol Med Rep       Date:  2017-08-31       Impact factor: 2.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.